Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
1,751
Price
$460.43
Total Value
$806.21K
Shares Held After
22,046
% of Holdings
7.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
1,925
Price
$460.43
Total Value
$886.33K
Shares Held After
20,819
% of Holdings
8.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
2,021
Price
$460.43
Total Value
$930.53K
Shares Held After
12,914
% of Holdings
13.5%
Tectonic Therapeutic, Inc. (TECX)
REICIN ALISE — Director
Shares
2,500
Price
$21.10
Total Value
$52.75K
Shares Held After
237,547
% of Holdings
1.1%
Ernexa Therapeutics Inc. (ERNA)
Cherington Charles — 10% Owner
Shares
4,000,000
Price
$0.50
Total Value
$2.00M
Shares Held After
6,779,440
% of Holdings
59.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$104.76
Total Value
$10.48K
Shares Held After
122,824
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
700
Price
$103.68
Total Value
$72.57K
Shares Held After
122,924
% of Holdings
0.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,913
Price
$102.66
Total Value
$196.38K
Shares Held After
123,624
% of Holdings
1.5%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
521,739
Price
$5.75
Total Value
$3.00M
Shares Held After
11,931,839
% of Holdings
4.4%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
6,622
Price
$18.12
Total Value
$119.99K
Shares Held After
351,611
% of Holdings
1.8%
MapLight Therapeutics, Inc. (MPLT)
Garnett Timothy John — Director
Shares
14,124
Price
$17.89
Total Value
$252.68K
Shares Held After
14,124
% of Holdings
100.0%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
182,295
Price
$0.82
Total Value
$148.77K
Shares Held After
4,803,275
% of Holdings
3.7%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
161,422
Price
$0.82
Total Value
$131.74K
Shares Held After
4,253,298
% of Holdings
3.7%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
110
Price
$45.00
Total Value
$4.95K
Shares Held After
12,546
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,960
Price
$72.27
Total Value
$430.75K
Shares Held After
4,498,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,040
Price
$71.80
Total Value
$1.01M
Shares Held After
4,504,407
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,799
Price
$72.28
Total Value
$419.17K
Shares Held After
695,686
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,201
Price
$71.80
Total Value
$1.02M
Shares Held After
701,485
% of Holdings
2.0%
Sagimet Biosciences Inc. (SGMT)
Rozek Elizabeth — Chief Legal & Admin. Officer
Shares
2,622
Price
$5.36
Total Value
$14.05K
Shares Held After
190,959
% of Holdings
1.4%
Sagimet Biosciences Inc. (SGMT)
Martins Eduardo Bruno — Chief Medical Officer
Shares
3,640
Price
$5.36
Total Value
$19.51K
Shares Held After
103,296
% of Holdings
3.4%
Sagimet Biosciences Inc. (SGMT)
Chauche Thierry — Chief Financial Officer
Shares
1,312
Price
$5.36
Total Value
$7.03K
Shares Held After
15,688
% of Holdings
7.7%
Sagimet Biosciences Inc. (SGMT)
Happel David — Director
Shares
12,101
Price
$5.36
Total Value
$64.86K
Shares Held After
677,621
% of Holdings
1.8%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
2,434
Price
$10.27
Total Value
$25.00K
Shares Held After
582,072
% of Holdings
0.4%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
254
Price
$23.12
Total Value
$5.87K
Shares Held After
15,637
% of Holdings
1.6%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
147
Price
$23.12
Total Value
$3.40K
Shares Held After
18,609
% of Holdings
0.8%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
109
Price
$23.12
Total Value
$2.52K
Shares Held After
19,031
% of Holdings
0.6%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
438
Price
$23.12
Total Value
$10.13K
Shares Held After
81,721
% of Holdings
0.5%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
590
Price
$14.11
Total Value
$8.32K
Shares Held After
58,052
% of Holdings
1.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
589
Price
$13.65
Total Value
$8.04K
Shares Held After
58,642
% of Holdings
1.0%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
441
Price
$14.11
Total Value
$6.22K
Shares Held After
59,574
% of Holdings
0.7%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
440
Price
$13.65
Total Value
$6.01K
Shares Held After
60,015
% of Holdings
0.7%
Tectonic Therapeutic, Inc. (TECX)
Lochner Daniel — Chief Financial Officer
Shares
6,000
Price
$21.61
Total Value
$129.66K
Shares Held After
32,044
% of Holdings
18.7%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
3,525
Price
$3.85
Total Value
$13.57K
Shares Held After
153,193
% of Holdings
2.2%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
12,192
Price
$3.78
Total Value
$46.09K
Shares Held After
509,989
% of Holdings
2.3%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
4,569
Price
$3.85
Total Value
$17.59K
Shares Held After
210,078
% of Holdings
2.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
6,894
Price
$2.42
Total Value
$16.70K
Shares Held After
146,506
% of Holdings
4.5%
Wave Life Sciences Ltd. (WVE)
Vargeese Chandra — Chief Technology Officer, Head of Platform Discovery Sciences
Shares
3,228
Price
$13.45
Total Value
$43.42K
Shares Held After
408,246
% of Holdings
0.8%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
1,883
Price
$13.45
Total Value
$25.33K
Shares Held After
61,867
% of Holdings
3.0%
Wave Life Sciences Ltd. (WVE)
Moran Kyle — Chief Financial Officer
Shares
3,588
Price
$13.45
Total Value
$48.26K
Shares Held After
134,385
% of Holdings
2.6%
Wave Life Sciences Ltd. (WVE)
BOLNO PAUL — Director
Shares
10,480
Price
$13.45
Total Value
$140.96K
Shares Held After
275,520
% of Holdings
3.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.21
Total Value
$65.59K
Shares Held After
50,437
% of Holdings
4.1%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
96
Price
$277.88
Total Value
$26.68K
Shares Held After
19,318
% of Holdings
0.5%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
400
Price
$275.68
Total Value
$110.27K
Shares Held After
19,414
% of Holdings
2.0%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
552
Price
$274.64
Total Value
$151.60K
Shares Held After
19,814
% of Holdings
2.7%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
928
Price
$273.71
Total Value
$254.00K
Shares Held After
20,366
% of Holdings
4.4%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
2,824
Price
$272.51
Total Value
$769.56K
Shares Held After
21,294
% of Holdings
11.7%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
5,700
Price
$271.66
Total Value
$1.55M
Shares Held After
24,118
% of Holdings
19.1%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
2,000
Price
$270.56
Total Value
$541.12K
Shares Held After
29,818
% of Holdings
6.3%
Showing 601–650 of 936 transactions (page 13 of 19)